The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

T.F. Malivanova

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

T.A. Astrelina

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

I.V. Kobzeva

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

V.A. Nikitina

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

Yu.B. Suchkova

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

A.S. Ostashkin

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

D.Yu. Usupzhanova

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

V.A. Brunchukov

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

E.I. Dobrovolskaya

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

A.A. Rastorgueva

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

E.E. Lomonosova

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

E.S. Lubaeva

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

E.Yu. Kretova

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

N.G. Stepanyants

Burnazyan Federal Medical Biophysical Center of the FMBA of Russia;
Biomedical University of Innovation and Continuous Education, Burnazyan Federal Medical Biophysical Center of the FMBA of Russia

M.Yu. Sukhova

FSBI «SRC A.I. Burnasyan Federal Medical Biophysical Center» of Federal Medical Biological Agency

A.S. Samoylov

State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Autoimmune haplotype AH8.1 normalizes the level of tumor necrosis factor in the blood sera of breast cancer patients

Authors:

T.F. Malivanova, T.A. Astrelina, I.V. Kobzeva, V.A. Nikitina, Yu.B. Suchkova, A.S. Ostashkin, D.Yu. Usupzhanova, V.A. Brunchukov, E.I. Dobrovolskaya, A.A. Rastorgueva, E.E. Lomonosova, E.S. Lubaeva, E.Yu. Kretova, N.G. Stepanyants, M.Yu. Sukhova, A.S. Samoylov

More about the authors

Views: 331

Downloaded: 1


To cite this article:

Malivanova TF, Astrelina TA, Kobzeva IV, Nikitina VA, Suchkova YuB, Ostashkin AS, Usupzhanova DYu, Brunchukov VA, Dobrovolskaya EI, Rastorgueva AA, Lomonosova EE, Lubaeva ES, Kretova EYu, Stepanyants NG, Sukhova MYu, Samoylov AS. Autoimmune haplotype AH8.1 normalizes the level of tumor necrosis factor in the blood sera of breast cancer patients. Molecular Genetics, Microbiology and Virology. 2023;41(1):38‑45. (In Russ.)
https://doi.org/10.17116/molgen20234101138

Recommended articles:
Cost-effectiveness analysis of tala­zoparib and olaparib for breast cancer in adults. Medi­cal Technologies. Asse­ssment and Choice. 2023;(1):89-98
Quality of life in breast cancer patients after imme­diate two-stage reco­nstruction. Plastic Surgery and Aesthetic Medi­cine. 2023;(2):47-53
Comprehensive analysis of the effi­cacy of personalized reha­bilitation programs in patients with breast cancer. Voprosy kuro­rtologii, fizioterapii, i lechebnoi fizi­cheskoi kultury. 2023;(2):31-38
Cardiac moni­toring of neoadjuvant chemotherapy in a patient with breast cancer. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2023;(3):309-312

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.